Key Points
- Chemed EVP Spencer Lee sold 1,000 shares at an average price of $547.61, totaling $547,610. After the sale, he directly owned 12,931 shares, a 7.18% reduction in his position.
- Chemed reported quarterly EPS of $6.75, beating the $6.44 analyst consensus, while revenue of $690.94 million also topped estimates and rose 10.6% year over year.
- Analysts’ average rating was “Hold,” with an average price target of $603. The company also announced a quarterly dividend of $0.70 per share, equivalent to a 0.5% annual yield.
Chemed Corporation (NYSE:CHE - Get Free Report) EVP Spencer Lee sold 1,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $547.61, for a total transaction of $547,610.00. Following the sale, the executive vice president directly owned 12,931 shares of the company's stock, valued at approximately $7,081,144.91. The trade was a 7.18% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Chemed Price Performance
Shares of NYSE:CHE traded down $0.84 during trading on Friday, reaching $549.36. The stock had a trading volume of 73,522 shares, compared to its average volume of 159,157. The stock has a market capitalization of $7.15 billion, a PE ratio of 26.28, a P/E/G ratio of 2.09 and a beta of 0.50. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.11 and a quick ratio of 1.08. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $562.24. The business's 50-day moving average price is $516.95 and its 200 day moving average price is $467.59.
Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported $6.75 EPS for the quarter, topping analysts' consensus estimates of $6.44 by $0.31. The business had revenue of $690.94 million for the quarter, compared to analyst estimates of $685.04 million. Chemed had a return on equity of 35.18% and a net margin of 10.61%. Chemed's revenue for the quarter was up 10.6% on a year-over-year basis. During the same period in the prior year, the company earned $5.27 EPS. As a group, equities analysts predict that Chemed Corporation will post 24.05 earnings per share for the current year.
Chemed Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Shareholders of record on Monday, November 16th will be given a $0.70 dividend. The ex-dividend date is Monday, November 16th. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed's payout ratio is presently 13.40%.
Wall Street Analysts Forecast Growth
CHE has been the topic of a number of recent analyst reports. Weiss Ratings raised Chemed from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, October 8th. Bank of America restated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Oppenheimer raised their target price on Chemed from $590.00 to $625.00 and gave the company an "outperform" rating in a research note on Thursday, October 29th. UBS Group lifted their price target on Chemed from $650.00 to $675.00 and gave the company a "buy" rating in a report on Thursday, October 29th. Finally, Royal Bank Of Canada upped their price target on shares of Chemed from $548.00 to $585.00 and gave the stock a "sector perform" rating in a research report on Thursday, October 29th. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Chemed has an average rating of "Hold" and an average price target of $603.00.
Read Our Latest Stock Analysis on CHE
Institutional Trading of Chemed
Several hedge funds have recently modified their holdings of CHE. Quantbot Technologies LP acquired a new stake in Chemed in the 2nd quarter valued at $1,726,000. The Manufacturers Life Insurance Company bought a new stake in Chemed during the 2nd quarter worth about $4,413,000. Lone Peak Global Investors LLC boosted its stake in shares of Chemed by 38.1% during the 2nd quarter. Lone Peak Global Investors LLC now owns 37,099 shares of the company's stock worth $17,279,000 after buying an additional 10,226 shares during the last quarter. Hsbc Holdings PLC boosted its stake in shares of Chemed by 41.7% during the 2nd quarter. Hsbc Holdings PLC now owns 12,346 shares of the company's stock worth $5,729,000 after buying an additional 3,632 shares during the last quarter. Finally, Amundi boosted its stake in shares of Chemed by 51.5% during the 2nd quarter. Amundi now owns 53,856 shares of the company's stock worth $25,083,000 after buying an additional 18,301 shares during the last quarter. 95.85% of the stock is owned by institutional investors.
About Chemed
(
Get Free Report)
Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
